Selective ABO immunoadsorption in hematopoietic stem cell transplantation with major ABO incompatibility
M Crysandt, H Soysal, E Jennes… - European Journal of …, 2021 - Wiley Online Library
Objective ABO mismatch between donor and recipient occurs in 40% of allogeneic
hematopoietic stem cell transplantations (HCT). Different strategies have been described to …
hematopoietic stem cell transplantations (HCT). Different strategies have been described to …
ABO incompatibility and non myeloablative allogeneic stem cell transplantation
JV Malfuson, Y Hicheri, P Bonin, M Rodet… - … et Biologique: Journal …, 2007 - europepmc.org
ABO incompatibility is not a barrier for allogeneic hematopoietic stem cell transplantation but
is associated with specific complications. Major ABO incompatibility is associated with …
is associated with specific complications. Major ABO incompatibility is associated with …
Investigation of risk factors associated with erythrocyte engraftment after ABO‐incompatible hematopoietic stem cell transplantation
R Yanagisawa, H Nakazawa, S Nishina… - Clinical …, 2021 - Wiley Online Library
ABO‐incompatible hematopoietic stem cell transplantations (HSCTs) are widely practiced;
however, the delay in erythrocyte engraftment can be problematic. While erythrocyte …
however, the delay in erythrocyte engraftment can be problematic. While erythrocyte …
Higher Anti‐A/B isoagglutinin titers of IgG class, but not of IgM, are associated with increased red blood cell transfusion requirements in bone marrow transplantation …
GC De Santis, AC Garcia‐Silva, GM Dotoli… - Clinical …, 2017 - Wiley Online Library
Background Major ABO mismatch between donor and recipient in bone marrow
transplantation (BMT) may cause hemolysis, delayed red blood cell (RBC) engraftment and …
transplantation (BMT) may cause hemolysis, delayed red blood cell (RBC) engraftment and …
Removal of persisting isohaemagglutinins with Ig-Therasorb® immunoadsorption after major ABO-incompatible non-myeloablative allogeneic haematopoietic stem …
W Rabitsch, P Knöbl, H Greinix, E Prinz… - Nephrology Dialysis …, 2003 - academic.oup.com
Background. Major ABO-incompatibility can be associated with haemolysis, prolonged red
cell aplasia (PRCA) and higher peri-transplant mortality resulting from organ toxicity after …
cell aplasia (PRCA) and higher peri-transplant mortality resulting from organ toxicity after …
[HTML][HTML] Immuno-Hematologic Complexity of ABO-Incompatible Allogeneic HSC Transplantation
A Matteocci, L Pierelli - Cells, 2024 - mdpi.com
ABO incompatibility is not considered a contraindication for hematopoietic stem cell
transplantation (HSCT). Approximately 30% of transplants from related donors and up to …
transplantation (HSCT). Approximately 30% of transplants from related donors and up to …
Haemolysis, pure red cell aplsasia and red cell antibody formation associated with major and bidirectional ABO incompatible haematopoietic stem cell transplantation
Background. Acute and delayed haemolysis, alloimmunisation and pure red cell aplasia
(PRCA) are potential complications after ABO incompatible haematopoietic stem cell …
(PRCA) are potential complications after ABO incompatible haematopoietic stem cell …
[HTML][HTML] Haemolysis, pure red cell aplasia and red cell antibody formation associated with major and bidirectional ABO incompatible haematopoietic stem cell …
Background Acute and delayed haemolysis, alloimmunisation and pure red cell aplasia
(PRCA) are potential complications after ABO incompatible haematopoietic stem cell …
(PRCA) are potential complications after ABO incompatible haematopoietic stem cell …
[HTML][HTML] Clinical impact of recipient-derived isoagglutinin levels in ABO-incompatible hematopoietic stem cell transplantation
M Nam, M Hur, H Kim, TH Lee, GH Lee, S Yoon… - Journal of Clinical …, 2023 - mdpi.com
ABO incompatibility is not considered a contraindication for hematopoietic stem cell
transplantation (HSCT). We hypothesized that recipient-derived isoagglutinin (RDI) levels …
transplantation (HSCT). We hypothesized that recipient-derived isoagglutinin (RDI) levels …
Donor‐type red blood cell transfusion to deplete isoagglutinins prior to allogeneic stem cell transplantation from ABO major incompatible bone marrow donors
A Jarisch, E Salzmann‐Manrique… - British Journal of …, 2023 - Wiley Online Library
ABO incompatibility affects approximately 40% of allogeneic stem cell transplants in
Caucasian patient populations. Because bone marrow (BM), the preferred graft from …
Caucasian patient populations. Because bone marrow (BM), the preferred graft from …